BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 29, 2012
View Archived Issues
Novel shRNA molecule demonstrates potential efficacy for patients with mesothelioma
Read More
Enrollment commences in new phase II study of ELND-005
Read More
TAS-114 demonstrates promising antitumor activity in combination with other oncolytic agents
Read More
Selecta Biosciences and Sanofi sign global collaboration to develop allergy immunotherapies
Read More
AiCuris begins second trial of pritelivir for genital herpes
Read More
GW Pharmaceuticals identifies novel oral cannabinoid candidate for type 2 diabetes
Read More
Novel, orally bioavailable HSP 90 inhibitor developed by Taiho for cancer
Read More
Phase I and II data reveal efficacy of AMG-145
Read More
Linaclotide receives European marketing approval for IBS-C
Read More
New APE-1 inhibitors presented by U.S. Department of Health & Human Services
Read More
Usher III Initiative prepares novel compounds for Usher syndrome
Read More
Polish group designs novel agents for HCMV infection
Read More
Researchers at Merck & Co. disclose new B-raf inhibitors
Read More
APY-0201 significantly ameliorates skin inflammation in animal models of psoriasis
Read More
ElexoPharm and Merck & Co. cooperate on novel series of CYP11B2 inhibitors
Read More
FDA accepts tivozanib NDA filing
Read More
Safety and pharmacokinetic phase I data reported for MGL-3196
Read More
NovImmune begins phase I study of NI-0101
Read More
NICE recommends Bronchitol for adults with cystic fibrosis
Read More
Mochida Pharmaceutical patents new GRP40 receptor agonists
Read More
Novel heat shock protein HSP 90 inhibitor prodrugs prepared at Myrexis
Read More
NICE recommends ivabradine for patients with chronic heart failure
Read More
Coronado Biosciences begins phase I/II trial of CNDO-109
Read More
NPS licenses rights to teduglutide in Israel to Neopharm
Read More
First clinical data on RG-7212 show target modulation and signs of efficacy
Read More
Biotron begins extended preclinical toxicology studies of BIT-225
Read More
FDA committee recommends accelerated approval of bedaquiline NDA
Read More
Kowa and Sanwa Kagaku Kenkyusho set to launch Suiny in Japan
Read More